Company intelligence / Profile preview
Lei Yun Shang
- Ownership
- Private
- Development stage
- Other
Overview
Lei Yun Shang is a leading heritage brand in China’s traditional Chinese medicine sector with nearly 300 years of history. It manufactures a wide range of TCM products for various indications including liver disease and cardiovascular conditions. The company integrates modern R&D with classical formulations and has received national recognition for quality control and innovation[1][2]. No Western-style clinical trial results are publicly reported.
- Therapeutic areas
- NephrologyOncologyGastroenterologyCardiovascularNeurologyInfectious Diseases
- Modalities
- Small moleculeHerbal medicineTraditional Chinese medicine compound preparations
- Industry
- Pharma
Drug pipeline
18 assets17 more assets in the full pipeline.
Beyond the preview
Go deeper on Lei Yun Shang.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lei Yun Shang.